Author Correction: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
1 Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China.
2 Department of Emergency Medicine, the Second Affiliated Hospital, Southeast University, Nanjing, 210002, China.
3 Department of Respiratory Medicine, the First People's Hospital of Nantong, Nantong, 226000, China.
4 Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China. yishi201607@163.com.